Information Center
Tiger Fu Tiger Nong Skin Antibacterial Agent, inhibits fungi, improves skin itching and inflammation.
Release time:
2023-09-14 20:33
So far,the pathophysiology of itchingremainslargely unknown,and theeffectiveness of drug treatments for itching is also poor. Current knowledge advancements in the management of itching and the various mediators and receptors involved have led to multiple potential treatment pathways. Currently, antiIL31, anti-IL4/13, anti-NK1, opioids, cannabinoids, anti-JAK, anti-phosphodiesterase-4, or anti-Trp are the main compounds undergoing clinical trials.The pathogenesis of chronic itchingis still unclear, aiming to identify therapeutic targets and new treatment methods,drug research is still in the exploratory research phase.
Through years of exploration and development, our company has discovered a new treatment approach that replaces hormone therapy with non-hormonal therapy, which is safer, more effective, and provides a lasting improvement for skin issues.
Tiger Fu Tiger Nong skin antibacterial agent inhibits fungi, improves skin itching and inflammation, whichis an unexpected new approach,that heralds a new theory, new medicine, and new model for managing skin issues.
Itching(or pruritus) is defined as an uncomfortable sensation that provokes the desire to scratch in response to chemical, mechanical, or thermal stimuli.
Chronic itching(CP) is classically divided into four clinical types, but its pathophysiological mechanisms are not well understood:
(1)Skin itching caused by skin diseases;
(2)Systemic itching associated with drugs and dermatoses;
(3)Neurogenic itching secondary to neurological diseases;
(4)Psychogenic itching caused by mental disorders.
Therefore, skin itching is often associated with allergic, inflammatory, or infectious diseases and insect bites, while systemic itching may be secondary to drugs or diseases of the liver, kidneys, blood, or other organs.
Neuropathy is more commonly associated with peripheral neuropathy. Psychological factors may influence itching of any cause, but there is also a specific psychogenic itching. Mixed itching is common. If possible, in addition to any strategies used to relieve itching, a key treatment strategy is to address the underlying cause. However, chronic itching will appear within weeks, and the specific mechanisms are not directly related to the initial cause of itching.
Chronic itching cansignificantly affectquality of life, demonstrating the need to improve treatment regimens to alleviate it. Current treatment methods are unsatisfactory as they are effective for only a small subset of patients, and the level of evidence is low. Recommendations are generally based on expert opinion.
With the emergence of increasingly fascinating new discoveries in the pathophysiology of itching, a variety of treatment optionsare being researched.In some cases, the results of clinical trials have been disappointing.Researchers are looking forward tofour families of drugs bringing revolutionary changes to itching treatment: antiIL31, anti-IL4/IL13, NK1 inhibitors, andopioids..However, these drugs still have a long way to go in terms of clinical efficacy and safety.
Tiger Fu Tiger Nong skin antibacterial agent belongs to plant products, which can act quickly, relieve itching, and reduce inflammation. After years of research and user experience, a new path and theory for alleviating and resolving skin issues have been found.
Related News
Beijing Address: A203, Zhongguancun Biomedical Park, No.5, Development Road, Haidian District, Beijing
Zhejiang Address: Floor 8, Building 7, Dongsheng Huigu, 1299 Kehai Avenue, Keqiao District, Shaoxing City, Zhejiang Province
Contact Phone:010-82176552
E-mail:hr@kanovabiopharma.com